Preparation of Alzheimers Animal Model and Brain Dysfunction Induced by Continuous $\beta$ -Amyloid Protein Infusion

Alzheimer's disease (AD) is the most common cause of dementia in the elderly, and its pathology is characterized by the presence of numerous numbers of senile plaques and neurofibrillary tangles. Several genetic and transgenic studies have indicated that excess amount of -amyloid protein (A) is produced by mutations of TEX>$\beta$-amyloid precursor protein and causes learning impairment. Moreover, has a toxic effect on cultured nerve cells. To prepare AD model animals, we have examined continuous (2 weeks) infusion of into the cerebral ventricle of rats. Continuous infusion of induces learning impairment in water maze and passive avoidance tasks, and decreases choline acetyltransferase activity in the frontal cortex and hippocampus. Immunohistochemical analysis revealed diffuse depositions of in the cerebral cortex and hippocampus around the ventricle. Furthermore, the nicotine-evoked release of acetylcholine and dopamine in the frontal cortex/hippocampus and striatum, respectively, is decreased in the -infused group. Perfusion of nicotine (50 ) reduced the amplitude of electrically evoked population spikes in the CA1 pyramidal cells of the control group, but not in those of the -infused group, suggesting the impairment of nicotinic signaling in the -infused group. In fact, Kd, but not Bmax, values for ［］ cytisine binding in the hippocampus significantly increased in the -infused rats. suggesting the decrease in affinity of nicotinic acetylcholine receptors. Long-term potentiation (LTP) induced by tetanic stimulations in CA1 pyramidal cells, which is thought to be an essential mechanism underlying learning and memory, was readily observed in the control group, whereas it was impaired in the -infused group. Taken together, these results suggest that infusion impairs the signal transduction mechanisms via nicotinic acetylcholine receptors. This dysfunction may be responsible, at least in part, for the impairment of LTP induction and may lead to learning and memory impairment. We also found the reduction of glutathione- and Mn-superoxide dismutase-like immunoreactivity in the brains of -infused rats. Administration of antioxidants or nootropics alleviated learning and memory impairment induced by infusion. We believe that investigation of currently available transgenic and non-transgenic animal models for AD will help to clarify the pathogenic mechanisms and allow assessment of new therapeutic strategies.